These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 122391)

  • 1. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW; James TA
    Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions between dopamine and gamma-aminobutyrate in the substantia nigra: implications for the striatonigral output hypothesis.
    Starr MS; Summerhayes M; Kilpatrick IC
    Neuroscience; 1983 Mar; 8(3):547-59. PubMed ID: 6856085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the involvement of nigrothalamic GABA neurons in circling behaviour in the rat.
    Kilpatrick IC; Starr MS; James TA; MacLeod NK
    Adv Biochem Psychopharmacol; 1981; 30():205-24. PubMed ID: 7331935
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of GABA in the substantia nigra.
    James TA; Starr MS
    Nature; 1978 Sep; 275(5677):229-30. PubMed ID: 692697
    [No Abstract]   [Full Text] [Related]  

  • 5. Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: striatal dopamine and GABA-mediated responses of pars reticulata neurons.
    Cools AR; Jaspers R; Kolasiewicz W; Sontag KH; Wolfarth S
    Behav Brain Res; 1983 Jan; 7(1):39-49. PubMed ID: 6297521
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional mechanism of the striatum by integration of nine types of synapses which have at least seven different transmitters.
    Hassler R
    Int J Neurol; 1979; 13(1-4):94-116. PubMed ID: 45452
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW; Garcia-Munoz M; Nicolaou NM; Tulloch IF; Wright AK
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract]   [Full Text] [Related]  

  • 9. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphofunctional features of the substantia nigra, its role in brain pathology and the action of pharmacologic substances].
    Arushanian EB
    Usp Fiziol Nauk; 1979; 10(2):45-72. PubMed ID: 38580
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the transmitters of the afferent and efferent pathways of the striatum and their interaction in the baboon, cat and rat.
    Kim JS
    Appl Neurophysiol; 1979; 42(1-2):62-4. PubMed ID: 36837
    [No Abstract]   [Full Text] [Related]  

  • 12. GABA-dopamine interaction in substantia nigra and nucleus accumbens--relevance to behavioral stimulation and stereotyped behavior.
    Scheel-Krüger J; Arnt J; Braestrup C; Christensen AV; Cools AR; Magelund G
    Adv Biochem Psychopharmacol; 1978; 19():343-6. PubMed ID: 567933
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 14. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
    Olianas MC; De Montis GM; Mulas G; Tagliamonte A
    Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta.
    Sanderson P; Mavoungou R; Albe-Fessard D
    Neurosci Lett; 1986 Jun; 67(1):25-30. PubMed ID: 3014391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of homovanillic acid in vivo using microcomputer-controlled voltammetry: simultaneous monitoring of rat motor activity and striatal dopamine release.
    O'Neill RD; Fillenz M
    Neuroscience; 1985 Mar; 14(3):753-63. PubMed ID: 3921870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some neuroactive compounds in the substantia nigra.
    Krnjević K
    Adv Neurol; 1974; 5():145-52. PubMed ID: 4155230
    [No Abstract]   [Full Text] [Related]  

  • 19. The striatum and substantia nigra: a commentary on their relationships.
    Dray A
    Neuroscience; 1979; 4(10):1407-39. PubMed ID: 233319
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of the ventromedial nucleus of the thalamus in motor behaviour--I. Effects of focal injections of drugs.
    Starr MS; Summerhayes M
    Neuroscience; 1983 Dec; 10(4):1157-69. PubMed ID: 6320046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.